Maternal-newborn human immunodeficiency virus infection in Harlem. NLM AIDSLINE Important note: Information in this article was accurate in 1994. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Maternal-newborn human immunodeficiency virus infection in Harlem.

Arch Pediatr Adolesc Med. 1994 Aug;148(8):813-9. Unique Identifier : AIDSLINE MED/94319452
Nicholas SW; Bateman DA; Ng SK; Dedyo T; Heagarty MC; Department of Pediatrics, Harlem Hospital Center, College of; Physicians and Surgeons of Columbia University, New York, NY.


Abstract: OBJECTIVE: To determine the prevalence of human immunodeficiency virus type 1 (HIV-1) infection and its association with illicit drug use for mothers being delivered of infants at an inner-city municipal hospital. METHODS: We anonymously tested the umbilical cord blood for HIV-1 antibody of 98.1% (2971/3028) of singleton infants with birth weight greater than 500 g born during 1989 and linked the results to a maternal-infant database from which all identifying information had been removed. RESULTS: Overall, HIV-1 seroprevalence was 3.3% (99/2971). Among HIV-1-seropositive mothers, 79% (78/99) gave no history of ever using injected drugs. Seropositivity for HIV-1 was independently associated with history of maternal cocaine use during pregnancy (odds ratio, 3.55; 95% confidence interval, 2.18, 5.78), history of ever using injected drugs (odds ratio, 6.02; 95% confidence interval, 3.14, 11.6), positive serologic test result for syphilis during pregnancy (odds ratio, 3.37; 95% confidence interval, 1.94, 5.88), and increasing maternal age per year (odds ratio, 1.04; 95% confidence interval, 1.00, 1.09). Voluntary testing programs failed to identify 71% (70/99) of all HIV-1-infected women. Infants placed into foster care were eight times more likely to be HIV-1 seropositive than those discharged to their mothers. CONCLUSIONS: Most HIV-1-infected mothers seem to have acquired the infection via heterosexual transmission rather than via injected drug use. Associations of maternal HIV-1 infection with cocaine use, syphilis, and increasing age probably operate through behaviors that increase maternal risk of exposure to an HIV-1-infected sexual partner or, in the case of syphilis, also through biologic factors that may predispose to HIV-1 transmission. The failure of voluntary testing to identify most HIV-1-infected mothers provides a strong rationale for routine HIV-1 testing during pregnancy and in the newborn period.
Keywords: Adult AIDS Serodiagnosis Confidence Intervals Female Fetal Blood Human HIV Antibodies/*ANALYSIS HIV Infections/BLOOD/*EPIDEMIOLOGY/*TRANSMISSION *HIV Seroprevalence *HIV-1 Infant, Newborn Logistic Models Maternal Age Medical Record Linkage New York City/EPIDEMIOLOGY Odds Ratio *Population Surveillance Pregnancy Pregnancy Complications, Infectious/BLOOD/*EPIDEMIOLOGY/*ETIOLOGY Risk Factors Seroepidemiologic Methods Sex Behavior Substance Abuse, Intravenous/*COMPLICATIONS Support, Non-U.S. Gov't JOURNAL ARTICLE

KWDadultaidsserodiagnosisconfidenceintervalsfemalefetalbloodhumanhivantibodies/KWDanalysishivinfections/blood/KWDepidemiology/KWDtransmissionKWDhivseroprevalenceKWDhiv-1infant,newbornlogisticmodelsmaternalagemedicalrecordlinkagenewyorkcity/epidemiologyoddsratioKWDpopulationsurveillancepregnancypregnancycomplications,infectious/blood/KWDepidemiology/KWDetiologyriskfactorsseroepidemiologicmethodssexbehaviorsubstanceabuse,intravenous/KWDcomplicationssupport,non-uKWDsKWDgov'tjournalarticle
941130
M94B0737


Copyright © 1994 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1994. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1994. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .